C WorldWide Group’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-26,000
| Closed | -$152K | – | 138 |
|
|
2016
Q4 | $152K | Sell |
26,000
-490,110
| -95% | -$2.87M | ﹤0.01% | 120 |
|
|
2016
Q3 | $2.74M | Buy |
516,110
+95,000
| +23% | +$505K | 0.05% | 78 |
|
|
2016
Q2 | $2.79M | Hold |
421,110
| – | – | 0.05% | 63 |
|
|
2016
Q1 | $1.97M | Hold |
421,110
| – | – | 0.04% | 70 |
|
|
2015
Q4 | $2.13M | Hold |
421,110
| – | – | 0.04% | 77 |
|
|
2015
Q3 | $1.48M | Buy |
421,110
+1,110
| +0.3% | +$3.91K | 0.02% | 94 |
|
|
2015
Q2 | $4.19M | Sell |
420,000
-490,302
| -54% | -$4.89M | 0.06% | 64 |
|
|
2015
Q1 | $11.6M | Buy |
910,302
+104,800
| +13% | +$1.33M | 0.17% | 39 |
|
|
2014
Q4 | $11.4M | Sell |
805,502
-434,304
| -35% | -$6.15M | 0.17% | 39 |
|
|
2014
Q3 | $16.8M | Buy |
+1,239,806
| New | +$16.8M | 0.25% | 33 |
|